AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Imugene’s (ASX:IMU) VAXINIA Trial Shows Promising Progress in Bile Tract Cancer Treatment
November 05, 2024 11:24 AM AEDT| By Team Kalkine MediaHighlights,Imugene,achieves significant milestone in bile tract cancer treatment.,Patient in VAXINIA Phase 1 trial,maintains,complete response after two years.,U.S. patent extended to 2040, boosting longevity of CF33 oncolytic virotherapy.,Imugene Lt...
NanoViricides (NYSE: NNVC) Showcases Lead Drug Candidate NV-387 at Spartan Capital Investors Conference 2024
November 04, 2024 07:42 PM AEDT| By Team Kalkine MediaHighlights:,NV-387 successfully completes Phase I clinical trials, paving the way for further development.,Demonstrated antiviral activity against Influenza, RSV, COVID, and MPox/Smallpox.,Target market for NV-387 projected to exceed $10 billion by 2...
Positive Outlook Created for Nuclear Medicine Stocks After US Decision
November 04, 2024 03:56 PM AEDT| By Team Kalkine MediaHighlights,Telix Pharmaceuticals secures ongoing favorable US reimbursement for its prostate cancer imaging agent, Illucix.,Optiscan partners with Monash University to develop a flexible, AI-enabled gastrointestinal endomicroscope.,BOD Australia prep...
Impedimed Limited Engages in Share Issuance for Executive Team
November 04, 2024 03:37 PM AEDT| By Team Kalkine MediaHighlights,Impedimed Limited has issued 462,895 fully paid ordinary shares to executives as part of its Executive Share Plan.,This share issuance aligns executive interests with shareholder value, enhancing corporate governance.,The shares will be qu...
Telix Pharmaceuticals (ASX:TLX) Welcomes New US Medicare Payment Rule
November 04, 2024 01:22 PM AEDT| By Team Kalkine MediaHighlights,New US Medicare payment rule boosts,Telix,Pharmaceuticals’ growth outlook.,Rule enables pricing certainty for radiopharmaceutical innovations.,Policy change may promote diagnostic-based decisions over reimbursement structures.,Telix Pharma...
Telix Pharmaceuticals Welcomes CMS Decision on Radiopharmaceutical Payments
November 04, 2024 12:48 PM AEDT| By Team Kalkine MediaHighlights,CMS Decision,: The U.S. Centers for Medicare & Medicaid Services will provide separate payments for specialized diagnostic radiopharmaceuticals starting in 2025, ensuring equitable access for Medicare patients.,Impact on Telix Products,: T...
FDA Grants Argenica Therapeutics Key Designations for Infant Brain Injury Drug
October 30, 2024 06:01 PM AEDT| By Team Kalkine MediaHighlights,Argenica Therapeutics received FDA designations for its infant brain injury drug candidate, ARG-006.,Designations could lead to tax credits, fee exemptions, and potential market exclusivity.,Priority Review Voucher (PRV) possible, enhancin...
Tryptamine Therapeutics (ASX:TYP) Raises A$6M for Psychedelic Trials
October 30, 2024 01:09 PM AEDT| By Team Kalkine MediaHighlights,Tryptamine Therapeutics Ltd,gains,A$6 million funding for clinical trials of TRP-8803.,Major investors include the Merchant Biotech Fund and Dr. Daniel Tillett.,Funds support expanded clinical trials on psilocin’s therapeutic potential.,Tr...
Evaluating the Value and Growth of Pro Medicus Limited (ASX:PME)
October 29, 2024 03:53 PM AEDT| By Team Kalkine MediaHighlights,Pro Medicus Limited offers essential radiology IT solutions, supporting global healthcare systems.,The healthcare sector shows resilience and steady growth potential, especially in the IT and data solutions space.,PME’s share price trades...
Analyzing Insider Activity at Clarity Pharmaceuticals Ltd (ASX:CU6) Amid Recent Stock Surge
October 29, 2024 01:29 PM AEDT| By Team Kalkine MediaHighlights,Clarity,Pharmaceuticals,shares surged 11%, but insiders sold earlier at a lower price.,Significant insider ownership of 18% aligns with shareholder interests.,No insider transactions recorded in the past three months.,Clarity Pharmaceutica...
ResMed Shows Resilience Following Decline Due to Fat-Busting Drug News
October 28, 2024 03:52 PM AEDT| By Team Kalkine MediaHighlights,ResMed's Recovery: ResMed shares surged following strong quarterly results, rebounding from prior declines attributed to concerns over anti-obesity drugs.,Dimerix's Kidney Trial Update: Dimerix may receive favorable news regarding surrogat...
Insights Gained from Austco Healthcare Limited's (ASX: AHC) Stock Performance Regarding Financial Health
October 28, 2024 03:12 PM AEDT| By Team Kalkine MediaHighlights,Strong Stock Performance: Austco Healthcare's stock has increased by 15% over the past three months.,Impressive ROE: The company's return on equity (ROE) stands at 16%, significantly above the industry average of 7.3%.,Earnings Growth: Aus...
ResMed (ASX:RMD) Rides Strong Q1 Performance and Updated Price Target
October 28, 2024 02:20 PM AEDT| By Team Kalkine MediaHighlights,ResMed shares rise on robust first-quarter revenue growth.,Company benefits from rising demand for sleep-related health solutions.,Analysts adjust price target following impressive performance indicators.,ResMed (ASX:RMD), a prominent play...
Oneview Expands Patient Care Platform Partnership with Baxter Across U.S. and Canada
October 28, 2024 12:39 PM AEDT| By Team Kalkine MediaHighlights,Oneview,Healthcare extends Baxter partnership for enhanced patient care solutions.,Agreement now includes Canada alongside the U.S. market.,New product rollouts include digital solutions for patient engagement.,Oneview Healthcare Plc (ASX:...
CSL Ltd Shows Steady Growth with Solid Financials
October 25, 2024 04:54 PM AEDT| By Team Kalkine MediaHighlights,CSL Ltd continues to show steady revenue growth with rising profits.,The company's debt/equity ratio indicates a strong capital structure.,CSL reported a 14.6% return on equity, signaling efficient capital usage.,CSL Ltd (ASX:CSL) has seen...
ASX health stocks confirming FY25 projections noted
October 25, 2024 03:02 PM AEDT| By Team Kalkine MediaHighlights,Market Trends: The ASX health stocks experienced a decline of approximately 0.9% over the past five days, while the broader market fell by 1.46%.,Quarterly Reporting: Aroa Biosurgery and EBOS Group reaffirmed their financial guidance follo...
Arovella Strengthens Cash Position with $3 Million R&D Refund and Prepares for FDA Meeting
October 25, 2024 02:16 PM AEDT| By Team Kalkine MediaHighlights,Arovella,secures a $3 million R&D tax refund for FY2024, with more funding expected.,Progress,continues on,ALA-101 as the company prepares for clinical trials.,Arovella,forms a Clinical Advisory Board ahead of a crucial FDA meeting.,Arovel...
Live Verdure Ltd. Records the Issuance of 1 Million New Securities
October 24, 2024 06:04 PM AEDT| By Team Kalkine MediaHighlights,Live Verdure Ltd has announced the quotation of 1,000,000 new ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code LV1.,This development is positioned to enhance the company's visibility and accessibili...
Telix and Banks Boost ASX Performance, While Newmont and Fortescue Struggle with Soaring Costs
October 24, 2024 05:58 PM AEDT| By Team Kalkine MediaHighlights,Australian shares closed modestly lower following a mixed trading session, with significant impacts from disappointing updates in the mining sector.,Newmont and Fortescue reported disappointing earnings, contributing to declines in their s...
InhaleRx Limited's Share Count Increased by Nearly 18 Million
October 24, 2024 05:41 PM AEDT| By Team Kalkine MediaHighlights,InhaleRx Limited has listed nearly 18 million fully paid ordinary shares on the ASX.,This move follows a series of market transactions that indicate potential for growth.,The increased share availability may attract broader market attentio...
Advertise your brand on Kalkine Media